reduced Parkinson-like pathology in mice partly through gut microbiota changes, with live as a possible mediator.
Evidence
This chemically induced Parkinson's disease mouse study used isoliquiritigenin treatment, , and live or heat-killed P. distasonis gavage while measuring behavior, dopaminergic neurons, barriers, neuroinflammation, microbiota, and serum metabolites.
Caveat
The evidence is preclinical and based on induced mouse models, so it does not show that isoliquiritigenin or P. distasonis treats human Parkinson's disease.
Simplified
BACKGROUND: Increasing evidence implicates the gut microbiota in the pathogenesis of Parkinson's disease (PD). Microbiota-targeted interventions may be a promising therapeutic approach. (ISL), a natural flavonoid and primary pharmacological constituent of licorice (Glycyrrhiza), has neuroprotective effects. Whether this neuroprotection involves modulation of the gut microbiota is unclear.
PURPOSE: The study assessed whether ISL mediates neuroprotective in PD by modulating the gut microbiota, and investigated the functional involvement of (P. distasonis) in this process.
METHODS: Mice with chemically-induced PD were first treated with ISL via oral gavage to assess its therapeutic effects. To investigate the microbiota-mediated mechanisms, (FMT) from ISL-treated donors and direct gavage of live or heat-killed P. distasonis were performed in separate cohorts. Behavioral performance, dopaminergic neuron integrity, intestinal barrier function, neuroinflammation, gut microbiota composition, and serum metabolomic profiles were systematically evaluated.
RESULTS: ISL and FMT significantly improved motor deficits and protected dopaminergic neurons in the substantia nigra. ISL treatment compositionally reshaped the gut microbiota by suppressing pro-inflammatory genera and enriching beneficial bacteria, such as Parabacteroides. Oral administration of live P. distasonis fully reproduced the neuroprotective effects of ISL, including improved motor function, reduced neuroinflammation, restoration of blood-brain barrier integrity, and attenuation of intestinal mucosal damage. Heat-killed P. distasonis had no significant effects. Metabolomic analysis revealed that ISL and live P. distasonis jointly regulate neuroprotective pathways and metabolites related to the gut-brain axis.
CONCLUSION: ISL alleviates PD-related pathology partly through gut microbiota remodeling, with P. distasonis as a potential mediator.
Key numbers
20 of 30
Increase in Motor Activity
Mice treated with showed enhanced locomotion in behavioral tests.
3
Reduction in Inflammatory Cytokines
Measured cytokine levels in -treated mice after administration.
Full Text
We can’t show the full text here under this license.
